Evidence map›Paper›PMID 26913030›Full record

ArticleFrontiers in immunology2016

Early Ovariectomy Results in Reduced Numbers of CD11c+/CD11b+ Spleen Cells and Impacts Disease Expression in Murine Lupus.

Melissa A Cunningham, Jena R Wirth, Jennifer L Scott, Jackie Eudaly, Erin L Collins, Gary S Gilkeson

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
1.7field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Increased development of T-betClinical immunology (Orlando, Fla.) · 2023
    Article
  5. Article
  6. Review
  7. Recipient sex and estradiol levels affect transplant outcomes in an age-specific fashion.American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons · 2021
    Article
  8. Review
  9. Renin Activity in Heart Failure with Reduced Systolic Function-New Insights.International journal of molecular sciences · 2019
    Review
  10. Article
  11. Sex bias in autoimmunity.Current opinion in rheumatology · 2019
    Review
  12. Article
  13. Review
  14. Alpha 1 Antitrypsin Gene Therapy Extends the Lifespan of Lupus-Prone Mice.Molecular therapy. Methods & clinical development · 2018
    Article
  15. Article
  16. Circulating sex steroids coregulate adipose tissue immune cell populations in healthy men.American journal of physiology. Endocrinology and metabolism · 2017
    Article
  17. Article
  18. Article
  19. Ovarian hormones influence immune response to Staphylococcus aureus infection.The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Melissa A CunninghamDivision of Rheumatology and Immunology, Ralph H. Johnson Veterans Affairs Hospital, Medical University of South Carolina , Charleston, SC , USA.
Jena R WirthDivision of Rheumatology and Immunology, Ralph H. Johnson Veterans Affairs Hospital, Medical University of South Carolina , Charleston, SC , USA.
Jennifer L ScottDivision of Rheumatology and Immunology, Ralph H. Johnson Veterans Affairs Hospital, Medical University of South Carolina , Charleston, SC , USA.
Jackie EudalyDivision of Rheumatology and Immunology, Ralph H. Johnson Veterans Affairs Hospital, Medical University of South Carolina , Charleston, SC , USA.
Erin L CollinsDivision of Rheumatology and Immunology, Ralph H. Johnson Veterans Affairs Hospital, Medical University of South Carolina , Charleston, SC , USA.
Gary S GilkesonDivision of Rheumatology and Immunology, Ralph H. Johnson Veterans Affairs Hospital, Medical University of South Carolina , Charleston, SC , USA.
Medical University of South Carolina · USRalph H. Johnson VA Medical Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Ninety percent of those diagnosed with systemic lupus erythematosus are female, with peak incidence between the ages of 15 and 45, when women are most hormonally active. Despite significant research effort, the mechanisms underlying this sex bias remain unclear. We previously showed that a functional knockout of estrogen receptor alpha (ERα) resulted in significantly reduced renal disease and increased survival in murine lupus. Dendritic cell (DC) development, which requires both estrogen and ERα, is impacted, as is activation status and cytokine production. Since both estrogen and testosterone levels have immunomodulating effects, we presently studied the phenotype of NZM2410 lupus-prone mice following post- and prepubertal ovariectomy (OVX) ± estradiol (E2) replacement to determine the impact of hormonal status on disease expression and DC development in these mice. We observed a trend toward survival benefit in addition to decreased proteinuria and improved renal histology in the early OVX, but not late OVX- or E2-repleted WT mice. Interestingly, there was also a significant difference in splenic DC subsets by flow cytometry. Spleens from NZM mice OVX'd early had a significant decrease in proinflammatory CD11c+CD11b+ DCs (vs. unmanipulated WTs, late OVX- and E2-repleted mice). These early OVX'd animals also had a significant increase in tolerogenic CD11c+CD8a+ DCs vs. WT. These data join a growing body of evidence that supports a role for hormone modulation of DCs that likely impacts the penetrance and severity of autoimmune diseases, such as lupus.

Indexed as

dendritic cellsestrogenmouse modelsovariectomysystemic lupus erythematosus

Identifiers

PMID26913030
PMCPMC4753299
OpenAlexW2299822073

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.